Tesamorelin 20mg — Verification Report
From Sunrise BioResearch · Lot TESA20MAR26-01 · Tested April 2026
VialTalk
Tesamorelin 20mg
Sunrise BioResearch
Score
104.8
Grade
A++
Superlative
Lot TESA20MAR26-01
Tested April 2026
Report ID
9d3abd3c
Test
Method
Result
Status
PurityFull credit
HPLC
99.63%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentStrong
Gravimetric vs label claim
20 mg labeled · 20.93 mg tested
Strong
EndotoxinFull credit
USP <85> compendial
Screened
Full credit
Heavy metalsFull credit
USP <232>/<233> compendial
Screened
Full credit
SterilityFull credit
USP <71> compendial
Screened
Full credit
Batch conformityNot submitted
Not tested
Not tested
Not submitted
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/sunrise-bioresearch/coas/9d3abd3c-aff7-45a6-89c7-8376e443ee01